Hybridomas, which produce monoclonal antibodies, are made by fusing cells of the immune system with B lymphocytes and myeloma cells.
<h3>
What are Hybridomas?</h3>
- Large-scale production of monoclonal antibodies is made possible through hybridoma technology.
- An antigen that triggers an immune response is first injected into a mammal to begin the process.
- A specific sort of white blood cell called a B cell makes antibodies that bind to the antigen that has been injected.
- These antibody-producing B-cells are then removed from the animal and combined with immortal B cell cancer cells, or myeloma, to create a hybrid cell line known as a hybridoma.
- It possesses both longevity and procreative capacity of the myeloma and the antibody-producing capacity of the B-cell.
Hence, the creation of hybridomas, which result in the production of monoclonal antibodies, involves fusing immune system cells with B lymphocytes and myeloma cells.
To learn more about Hybridomas refer to:
brainly.com/question/15189667
#SPJ4
Answer:
:)
Explanation:
EHR systems in healthcare
An electronic health record (EHR) is the systematized collection of patient and population electronically stored health information in a digital format. These records can be shared across different health care settings. ... EHR systems are designed to store data accurately and to capture the state of a patient across time.
Answer:
it allows access and availability to most
Answer:
no blood is not suitable for donation as it will clot too much in the recipient patient and can cause severe problems.
Explanation:
